Your browser doesn't support javascript.
loading
Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.
Cruz, Francisco M; Macías, Álvaro; Moreno-Manuel, Ana I; Gutiérrez, Lilian K; Vera-Pedrosa, María Linarejos; Martínez-Carrascoso, Isabel; Sánchez Pérez, Patricia; Ruiz Robles, Juan Manuel; Bermúdez-Jiménez, Francisco J; Díaz-Agustín, Aitor; Martínez de Benito, Fernando; Arias-Santiago, Salvador; Braza-Boils, Aitana; Martín-Martínez, Mercedes; Gutierrez-Rodríguez, Marta; Bernal, Juan A; Zorio, Esther; Jiménez-Jaimez, Juan; Jalife, José.
Afiliación
  • Cruz FM; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Macías Á; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Moreno-Manuel AI; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Gutiérrez LK; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Vera-Pedrosa ML; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Martínez-Carrascoso I; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Sánchez Pérez P; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Ruiz Robles JM; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Bermúdez-Jiménez FJ; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Díaz-Agustín A; Servicio de Cardiología (F.J.B.-J., J.J.-J.), Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Martínez de Benito F; Instituto de Investigación Biosanitaria de Granada IBS (Instituto de investigaciones biosanitarias), Spain (F.J.B.-J., S.A.-S., J.J.-J.).
  • Arias-Santiago S; Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain (A.D.-A., M.M.-M., M.G.-R.).
  • Braza-Boils A; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (F.M.C., A.M., A.I.M.-M., L.K.G., M.L.V.-P., I.M.-C., P.S.P., J.M.R.R., F.J.B.-J., F.M.d.B., J.A.B., J.J.).
  • Martín-Martínez M; CIBER (Centro de Investigacion biomédica en Red) de Enfermedades Cardiovasculares, Madrid, Spain (F.M.d.B., J.A.B., E.Z., J.J.).
  • Gutierrez-Rodríguez M; Servicio de Dermatología (S.A.-S.), Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Bernal JA; Instituto de Investigación Biosanitaria de Granada IBS (Instituto de investigaciones biosanitarias), Spain (F.J.B.-J., S.A.-S., J.J.-J.).
  • Zorio E; Unit of Inherited Cardiomyopathies and Sudden Death (CAFAMUSME [Unidad de Cardiopatías Familiares, Muerte Súbita y Mecanismos de Enfermedad]), Health Research Institute La Fe, La Fe Hospital, Valencia, Spain (A.B.-B., E.Z.).
  • Jiménez-Jaimez J; Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain (A.D.-A., M.M.-M., M.G.-R.).
  • Jalife J; Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain (A.D.-A., M.M.-M., M.G.-R.).
Circ Res ; 134(8): e52-e71, 2024 Apr 12.
Article en En | MEDLINE | ID: mdl-38497220
ABSTRACT

BACKGROUND:

Andersen-Tawil syndrome type 1 is a rare heritable disease caused by mutations in the gene coding the strong inwardly rectifying K+ channel Kir2.1. The extracellular Cys (cysteine)122-to-Cys154 disulfide bond in the channel structure is crucial for proper folding but has not been associated with correct channel function at the membrane. We evaluated whether a human mutation at the Cys122-to-Cys154 disulfide bridge leads to Kir2.1 channel dysfunction and arrhythmias by reorganizing the overall Kir2.1 channel structure and destabilizing its open state.

METHODS:

We identified a Kir2.1 loss-of-function mutation (c.366 A>T; p.Cys122Tyr) in an ATS1 family. To investigate its pathophysiological implications, we generated an AAV9-mediated cardiac-specific mouse model expressing the Kir2.1C122Y variant. We employed a multidisciplinary approach, integrating patch clamping and intracardiac stimulation, molecular biology techniques, molecular dynamics, and bioluminescence resonance energy transfer experiments.

RESULTS:

Kir2.1C122Y mice recapitulated the ECG features of ATS1 independently of sex, including corrected QT prolongation, conduction defects, and increased arrhythmia susceptibility. Isolated Kir2.1C122Y cardiomyocytes showed significantly reduced inwardly rectifier K+ (IK1) and inward Na+ (INa) current densities independently of normal trafficking. Molecular dynamics predicted that the C122Y mutation provoked a conformational change over the 2000-ns simulation, characterized by a greater loss of hydrogen bonds between Kir2.1 and phosphatidylinositol 4,5-bisphosphate than wild type (WT). Therefore, the phosphatidylinositol 4,5-bisphosphate-binding pocket was destabilized, resulting in a lower conductance state compared with WT. Accordingly, on inside-out patch clamping, the C122Y mutation significantly blunted Kir2.1 sensitivity to increasing phosphatidylinositol 4,5-bisphosphate concentrations. In addition, the Kir2.1C122Y mutation resulted in channelosome degradation, demonstrating temporal instability of both Kir2.1 and NaV1.5 proteins.

CONCLUSIONS:

The extracellular Cys122-to-Cys154 disulfide bond in the tridimensional Kir2.1 channel structure is essential for the channel function. We demonstrate that breaking disulfide bonds in the extracellular domain disrupts phosphatidylinositol 4,5-bisphosphate-dependent regulation, leading to channel dysfunction and defects in Kir2.1 energetic stability. The mutation also alters functional expression of the NaV1.5 channel and ultimately leads to conduction disturbances and life-threatening arrhythmia characteristic of Andersen-Tawil syndrome type 1.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Andersen Límite: Animals / Humans Idioma: En Revista: Circ Res Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Andersen Límite: Animals / Humans Idioma: En Revista: Circ Res Año: 2024 Tipo del documento: Article